"10.1371_journal.pone.0043569","plos one","2012-08-22T00:00:00Z","Jos B Poell; Rick J van Haastert; Thijs de Gunst; Iman J Schultz; Willemijn M Gommans; Mark Verheul; Francesco Cerisoli; Paula I van Noort; Gregoire P Prevost; Roel Q J Schaapveld; Edwin Cuppen","Hubrecht Institute, University Medical Center Utrecht, Cancer Genomics Center, Utrecht, The Netherlands; InteRNA Technologies BV, Utrecht, The Netherlands","Conceived and designed the experiments: JP RH WG PN GP RS EC. Performed the experiments: JP RH TG IS WG MV FC. Analyzed the data: JP RH FC. Wrote the paper: JP RH EC.","Dr. van Haastert, Dr. Gommans, Dr. van Noort, Dr. Schaapveld are employees of InteRNA Technologies and hold shares in the company. InteRNA Technologies has filed for a patent on therapeutic application for cancer treatment using specific miRNAs as described in this manuscript. This application is currently in the PTC phase. The claims in this patent do not alter the authors adherence to or interfere with all the PLoS ONE policies on sharing data and materials.","2012","08","Jos B Poell","JBP",11,TRUE,7,7,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
